109 related articles for article (PubMed ID: 30024415)
41. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
[TBL] [Abstract][Full Text] [Related]
42. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism.
Xu H; Chilton PM; Huang Y; Schanie CL; Ildstad ST
J Immunol; 2004 Feb; 172(3):1463-71. PubMed ID: 14734723
[TBL] [Abstract][Full Text] [Related]
43. Pre-transplant co-infusion of donor-adipose tissue derived mesenchymal stem cells and hematopoietic stem cells may help in achieving tolerance in living donor renal transplantation.
Vanikar AV; Trivedi HL; Gopal SC; Kumar A; Dave SD
Ren Fail; 2014 Apr; 36(3):457-60. PubMed ID: 24344734
[TBL] [Abstract][Full Text] [Related]
44. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
Cosimi AB; Sachs DH; Sykes M; Kawai T
Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
[TBL] [Abstract][Full Text] [Related]
45. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras.
Kuhr CS; Allen MD; Junghanss C; Zaucha JM; Marsh CL; Yunusov M; Zellme E; Little MT; Torok-Storb B; Storb R
Transplantation; 2002 May; 73(9):1487-92. PubMed ID: 12023629
[TBL] [Abstract][Full Text] [Related]
46. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
[TBL] [Abstract][Full Text] [Related]
47. Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant tolerance.
Guo H; Li B; Wang W; Zhao N; Gao H
Stem Cell Res Ther; 2018 Sep; 9(1):254. PubMed ID: 30257721
[TBL] [Abstract][Full Text] [Related]
48. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys.
Kawai T; Cosimi AB; Colvin RB; Powelson J; Eason J; Kozlowski T; Sykes M; Monroy R; Tanaka M; Sachs DH
Transplantation; 1995 Jan; 59(2):256-62. PubMed ID: 7839449
[TBL] [Abstract][Full Text] [Related]
49. Transplantation tolerance through mixed chimerism: From allo to xeno.
Sachs DH
Xenotransplantation; 2018 May; 25(3):e12420. PubMed ID: 29913045
[TBL] [Abstract][Full Text] [Related]
50. Chimerism studies as an approach for the induction of tolerance to extremity allografts.
Muramatsu K; Kuriyama R; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T
J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1009-15. PubMed ID: 18573704
[TBL] [Abstract][Full Text] [Related]
51. Facilitating cells: Translation of hematopoietic chimerism to achieve clinical tolerance.
Ildstad ST; Leventhal J; Wen Y; Yolcu E
Chimerism; 2015 Apr; 6(1-2):33-9. PubMed ID: 26745761
[TBL] [Abstract][Full Text] [Related]
52. Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning.
Gleit ZL; Fuchimoto Y; Yamada K; Melendy E; Scheier-Dolberg R; Monajati L; Coburn RC; Neville DM; Sachs DH; Huang CA
Transplantation; 2002 Dec; 74(11):1535-44. PubMed ID: 12490786
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
Czekalska S; Sacha T; Piatkowska-Jakubas B; Zawada M; Florek I; Cwynar D; Skotnicki AB
Przegl Lek; 2010; 67(12):1282-91. PubMed ID: 21591354
[TBL] [Abstract][Full Text] [Related]
54. Biomarkers of immune tolerance in liver transplantation.
Vionnet J; Sánchez-Fueyo A
Hum Immunol; 2018 May; 79(5):388-394. PubMed ID: 29462637
[TBL] [Abstract][Full Text] [Related]
55. Clinical transplantation tolerance.
Newell KA
Semin Immunopathol; 2011 Mar; 33(2):91-104. PubMed ID: 21327773
[TBL] [Abstract][Full Text] [Related]
56. Apoptotic cell-based therapies for promoting transplantation tolerance.
Dangi A; Yu S; Luo X
Curr Opin Organ Transplant; 2018 Oct; 23(5):552-558. PubMed ID: 30024416
[TBL] [Abstract][Full Text] [Related]
57. Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures.
Dubouchet L; Todorov H; Seurinck R; Vallet N; Van Gassen S; Corneau A; Blanc C; Zouali H; Boland A; Deleuze JF; Ingram B; de Latour RP; Saeys Y; Socié G; Michonneau D
Sci Transl Med; 2022 Feb; 14(633):eabg3083. PubMed ID: 35196024
[TBL] [Abstract][Full Text] [Related]
58. Moving from transplant as a treatment to transplant as a cure.
Kant S; Brennan DC
J Clin Invest; 2020 May; 130(5):2189-2191. PubMed ID: 32250338
[TBL] [Abstract][Full Text] [Related]
59. Corrigendum: Immune tolerance induced by hematopoietic stem cell infusion after HLA identical sibling kidney transplantation.
Huang H; Shen Q; Zhou J; Yang X; Cai Q; Shen J; Feng S; Xie W; Jiang H; Chen J
Front Immunol; 2022; 13():1052676. PubMed ID: 36341386
[TBL] [Abstract][Full Text] [Related]
60. Signatures of Tolerance or Immunosuppression?
Markmann JF
Am J Transplant; 2016 Dec; 16(12):3320-3321. PubMed ID: 27467554
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
